Yong-Chen William Lu

14PUBLICATIONS
61CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 30, 2025
Isolation of mitochondrial mutation-specific T cell receptors.

Catherine Kirkpatrick, Shanshan Hao, Charles M Quick

|Jan 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.

Panagiota Maravelia, Haidong Yao, Curtis Cai

|May 10, 2024
Deciphering CD4+ T cell-mediated responses against cancer.

Catherine Kirkpatrick, Yong-Chen William Lu

|Jun 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.

Sanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis

|Feb 03, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.

Frank J Lowery, Sri Krishna, Rami Yossef

|Dec 10, 2021
Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy.

Lindy Davis, Ashley Tarduno, Yong-Chen Lu

Pageof 3

Frequent Collaborators

3 joint publications

Zhili Zheng

3 joint publications

Paul F Robbins

2 joint publications

Drew C Deniger

2 joint publications

Sivasish Sindiri